as on December 6, 2025 at 2:29 am IST
Day's Low
Day's High
1.47%
Downside
3.02%
Upside
52 Week's Low
52 Week's High
90.40%
Downside
6.45%
Upside
Check Cogent Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$6.0B
EPS (TTM)
-2.247
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-305.0M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-95.40%
Compare market cap, revenue, PE, and other key metrics of Cogent Biosciences Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $6.0B | 198% | NA | 0.00% | |
| BUY | $43.5B | 408.22% | -16.34 | -264.83% | |
| BUY | $61.5B | 253.6% | 1661.93 | 1.36% | |
| BUY | $117.3B | 99.49% | 32.16 | 31.35% | |
| BUY | $76.6B | 45.87% | 17.31 | 32.13% |
The Cogent Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Cogent Biosciences Inc investment value today
Current value as on today
₹4,42,276
Returns
₹3,42,276
(+342.28%)
Returns from Cogent Biosciences Inc Stock
₹3,36,108 (+336.11%)
Dollar Returns*
₹6,168 (+6.17%)
Based on 17 analysts
82.35%
Buy
17.65%
Hold
0.00%
Sell
Based on 17 analysts, 82.35% of analysts recommend a 'BUY' rating for Cogent Biosciences Inc. Average target price of $47.18
Get share price movements and forecasts by analysts on Cogent Biosciences Inc.
What analysts predicted
17.83%UPSIDE
Target Price
$47.18
Current Price
$38.77
Analyzed by
17 Analysts
Target
$47.18
Cogent Biosciences Inc target price $47.18, a slight upside of 17.83% compared to current price of $38.77. According to 17 analysts rating.
Investment in Cogent Biosciences Inc Shares on INDmoney has grown by 788.88% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:788.88% versus previous 30 day period
Search interest for Cogent Biosciences Inc Stock has increased by 990% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:990% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 10 November
Mon, 08:13 PM
-Cogent Biosciences shares surged 116% after positive Phase 3 PEAK trial results for bezuclastinib plus sunitinib in GIST patients.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
![]()
In the last 1 year, COGT has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 1 month, COGT stock has moved up by 163.4%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 974.8% return, outperforming this stock by 755.7%
| Organisation | Cogent Biosciences Inc |
| Headquarters | 275 Wyman Street, Waltham, MA, United States, 02451 |
| Industry | Health Technology |
| CEO | Mr. Andrew R. Robbins M.B.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Jessica Sachs M.D. | Chief Medical Officer |
Ms. Christi Waarich | Senior Director of Investor Relations |
Mr. Evan D. Kearns J.D. | Chief Legal Officer & Corporate Secretary |
Mr. Dana R. Martin Pharm.D. | Senior VP of Medical Affairs & Chief Patient Officer |
Ms. Erin Schellhammer | Chief People Officer |
Mr. Andrew R. Robbins M.B.A. | President, CEO & Director |
Mr. John L. Green C.A., CPA | CFO & Principal Accounting Officer |
Dr. John Edward Robinson Ph.D. | Chief Scientific Officer |
Mr. Cole Pinnow | Chief Commercial Officer |
Mr. Brad Barnett | Chief Technology Officer |
Cogent Biosciences Inc share price today is $38.77 as on at the close of the market. Cogent Biosciences Inc share today touched a day high of $39.94 and a low of $38.2.
Cogent Biosciences Inc share touched a 52 week high of $41.27 on and a 52 week low of $3.72 on . Cogent Biosciences Inc stock price today i.e. is closed at $38.77,which is 6.06% down from its 52 week high and 942.20% up from its 52 week low.
Cogent Biosciences Inc market capitalisation is $0.01T as on .
Indian investors can start investing in Cogent Biosciences Inc (COGT) shares with as little as ₹89.896 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹898.96 in Cogent Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Cogent Biosciences Inc share’s latest price of $38.77 as on December 6, 2025 at 2:29 am IST, you will get 0.2579 shares of Cogent Biosciences Inc. Learn more about
fractional shares .
Cogent Biosciences Inc stock has given 198% share price returns and 22.22% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?